Article Information
History
- October 4, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Justin R. Ortiz1,*,
- David I. Bernstein2,
- Daniel F. Hoft3,
- Christopher W. Woods4,
- Micah T. McClain4,
- Sharon E. Frey6,
- Rebecca C. Brady2,
- Christopher Bryant8,
- Ashley Wegel8,
- Robert W Frenck Jr.2,
- Emmanuel B. Walter11,
- Getahun Abate12,
- Sarah R. Williams13,
- Robert L. Atmar14,
- Wendy A. Keitel15,
- Nadine Rouphael16,
- Mathew J. Memoli17,
- Mamodikoe K. Makhene18,
- Paul C. Roberts18 and
- Kathleen M. Neuzil1
- 1Center for Vaccine Development & Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA
- 2Cincinnati Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA
- 3Departments of Internal Medicine & Molecular Microbiology and Immunology, Saint Louis University School of Medicine Division of Infectious Diseases, Allergy and Immunology and Center for Vaccine Development, Saint Louis, Missouri, USA
- 4Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA
- 6Department of Internal Medicine, Saint Louis University School of Medicine Division of Infectious Diseases, Allergy and Immunology and Center for Vaccine Development, Saint Louis, Missouri, USA
- 8The Emmes Company, Rockville, Maryland, USA
- 11Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA
- 12Departments of Internal Medicine, Saint Louis University School of Medicine Division of Infectious Diseases, Allergy and Immunology and Center for Vaccine Development, Saint Louis, Missouri, USA
- 13Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA
- 14Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
- 15Departments of Molecular Virology & Microbiology and Medicine, Baylor College of Medicine, Houston, TX, USA
- 16Hope Clinic of the Emory Vaccine Center, Division of Infectious Diseases, Department of Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA
- 17Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA
- 18Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA
- ↵* Corresponding author; email: jortiz{at}som.umaryland.edu
Posted October 04, 2022.
A Multi-Center, Controlled Human Infection Study of Influenza A (H1N1)pdm09 in Healthy Adults
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos